BOW NYSE Week ended 31 Jul 2026

Weekly Investor Report

Bowhead Specialty Holdings Inc. · Financial Services · Insurance - Property & Casualty

Open interactive chart View report data
Latest close 30.59 USD
-1.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 17.2% above the Trend Line and sits at 78.2% of its 52-week range. The latest completed week returned -1.7%, after a -2.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 60/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 48 out of 100
Latest Close 30.59 USD 31 Jul 2026
1W Return -1.7% latest completed week
4W Return -2.8% short-term follow-through
12W Return 13.0% quarterly tape
Trend Breadth 11.5% 6 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 41.53% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.7% Latest completed week; four-week move -2.8%. Indicator stack 27/75 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 41.53% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 60/100 37 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 17.2% above the Trend Line and sits at 78.2% of its 52-week range. The latest completed week returned -1.7%, after a -2.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7212-week average 0.42

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.72Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.8% over four weeks, 13.0% over 12 weeks, and -4.2% over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W-1.7%
4W-2.8%
12W13.0%
26W24.6%
52W-4.2%
Active trend streak6 weeks
Active weeks in one year6
Trend breadth11.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.33Latest activity-pressure read.
Pressure change17.8%Four-week change in activity pressure.
Leadership4.85Latest relative-leadership reading.
RS change-16.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength80/100Blend of value, momentum, and quality. Underlying universe rank 21; rank 1 is best.
Value83/100Relative valuation strength. Underlying universe rank 18; rank 1 is best.
Quality68/100Profitability and accounting quality. Underlying universe rank 33; rank 1 is best.
Momentum23/100Medium-term price momentum. Underlying universe rank 78; rank 1 is best.
Growth92/100Revenue and earnings growth. Underlying universe rank 9; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
17.5x
Price divided by trailing earnings.
Price / sales
1.8x
Market value relative to trailing revenue.
EV / EBITDA
13.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
33.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
34.4%
Gross profit retained from each unit of revenue.
Operating margin
13.4%
Operating profit retained from revenue.
Free-cash-flow margin
60.5%
Free cash flow generated from revenue.
Return on invested capital
12.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
27.5%
Latest one-year revenue growth.
EPS growth
36.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
16.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment60/100

Weighted news tone is neutral across 37 relevant articles.

21 positive · 15 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-7.9%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2611 weeks finished lower.
Best week+11.3%Week of 8 May.
Worst week-6.0%Week of 6 Mar.
Latest week-1.7%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains8
Flat weeks1
Modest losses7
Sharp losses4
Recent vol4.9%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split23/28Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape47/100

Trend, activity pressure, participation, and risk combine to a 47/100 tape read.

 Indicator analysis65/100

Latest 12-week confirmation: trend 6/12, activity pressure 12/12, relative leadership 6/12.

Activity pressure 0.72; No reversal markers Next-Week ExpectancyNegative 41.53%

Next-week expectancy is negative with a 41.53% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors64/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 62; Small Cap Core rank 39 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment60/100

Weighted news tone is neutral across 37 relevant articles.

Bowhead Specialty Holdings Inc expected to post earnings of 47 cents a share - Earnings Preview Insiders50/100

No recent insider transaction evidence is stored.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202630.59 USD-1.7%26.09 USD29.97 USD1.334.85609.6KOn
24 Jul 202631.11 USD1.3%25.99 USD29.97 USD1.387.22713.1KOn
17 Jul 202630.70 USD-2.2%25.90 USD29.96 USD1.484.67953.2KOn
10 Jul 202631.39 USD-0.3%25.81 USD29.95 USD1.304.71972.8KOn
3 Jul 202631.48 USD5.7%25.69 USD29.94 USD1.135.81702.2KOn
26 Jun 202629.77 USD9.1%25.49 USD29.92 USD0.951.471.5MOn
19 Jun 202627.28 USD-0.1%25.43 USD29.93 USD0.75-10.11543.1KOff
12 Jun 202627.32 USD6.1%25.44 USD29.95 USD0.90-10.22774.0KOff
5 Jun 202625.75 USD-3.3%25.45 USD29.97 USD1.05-15.88876.5KOff
29 May 202626.62 USD-5.9%25.45 USD30.01 USD1.24-16.24768.6KOff
22 May 202628.30 USD0.2%25.36 USD30.05 USD1.23-10.841.0MOff
15 May 202628.25 USD4.4%25.25 USD30.06 USD0.99-11.281.4MOff
8 May 202627.06 USD11.3%25.16 USD30.08 USD0.70-15.861.6MOff
1 May 202624.32 USD1.5%25.13 USD30.11 USD0.29-23.751.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.